CAS: 1216744-19-2
![1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate](https://static.cymitquimica.com/products/AN/thumb/AG009CI5.jpg)
1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate
CAS:1216744-19-2
Formula:
C18H21ClN2O4S
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
396.8883
Ref: AN-AG009CI5
| 5mg | 100.00 € | |
| 10mg | 110.00 € | |
| 50mg | 142.00 € | |
| 100mg | 190.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
GSK4112
CAS:1216744-19-2
GSK4112 (SR6452) is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small …
Formula:
C18H21ClN2O4S
Purity:
99.69%
Color and Shape:
Solid
Molecular weight:
396.89
Ref: TM-T5045
| 5mg | 51.00 € | |
| 10mg | 83.00 € | |
| 25mg | 157.00 € | |
| 50mg | 276.00 € | |
| 100mg | 495.00 € | |
| 1ml*10 (DMSO) | 52.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
GSK 4112
CAS:1216744-19-2
Applications GSK 4112 is a synthetic ligand for REV-ERBα, a member of the nuclear receptor …
Formula:
C18H21ClN2O4S
Color and Shape:
Pale Yellow to Light Yellow Solid
Molecular weight:
396.89
Ref: TR-G797700
| 5mg | 93.00 € | |
| 50mg | 614.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
GSK4112
CAS:1216744-19-2
GSK4112 is a novel, orally bioavailable compound that is being developed for the treatment of …
Formula:
C18H21ClN2O4S
Purity:
Min. 95%
Molecular weight:
396.89 g/mol
Ref: 3D-RYB74419
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
